|
|
Substance Name: Succinylcholine
RN: 306-40-1
UNII: J2R869A8YF
InChIKey: AXOIZCJOOAYSMI-UHFFFAOYSA-N
Note
- A quaternary skeletal muscle relaxant usually used in the form of its bromide, chloride, or iodide. It is a depolarizing relaxant, acting in about 30 seconds and with a duration of effect averaging three to five minutes. Succinylcholine is used in surgical, anesthetic, and other procedures in which a brief period of muscle relaxation is called for.
Molecular Formula
- C14-H30-N2-O4
Molecular Weight
- 290.401
Classification Codes
- Drug / Therapeutic Agent
- Human Data
- Neuromuscular Agents
- Neuromuscular Blocking Agents
- Neuromuscular Depolarizing Agents
- Peripheral Nervous System Agents
* denotes mobile formatted website
Links to Resources
NLM Resources (File Locators)
Other Resources (Internet Locators)
Search for this InChIKey on the Web
Names and Synonyms
Name of Substance
- Succinylcholine
MeSH Heading
- Succinylcholine
Synonyms
- 4-04-00-01451 (Beilstein Handbook Reference)
- BRN 1805311
- Choline, succinate (2:1) (ester)
- Choline, succinate (ester)
- Choline, succinyl-
- Diacetylcholine
- Dicholine succinate
- Ditilin
- Ditiline
- Ethanaminium, 2,2'-((1,4-dioxo-1,4-butanediyl)bis(oxy))bis(N,N,N-trimethyl-
- HSDB 3254
- Succinic acid, diester with choline
- Succinocholine
- Succinoylcholine
- Succinyl choline
- Succinylbischoline
- Succinylcholine
- Succinyldicholine
- Suxamethonium
- UNII-J2R869A8YF
Systematic Names
- Choline, succinate (2:1) (ester)
- Ethanaminium, 2,2'-((1,4-dioxo-1,4-butanediyl)bis(oxy))bis(N,N,N-trimethyl-
Registry Numbers
CAS Registry Number
- 306-40-1
FDA UNII
- J2R869A8YF
Related Registry Numbers
- 541-19-5 (diiodide)
- 55-94-7 (dibromide)
- 71-27-2 (dichloride)
System Generated Number
- 0000306401
Structure Descriptors
InChI
InChI=1S/C14H30N2O4/c1-15(2,3)9-11-19-13(17)7-8-14(18)20-12-10-16(4,5)6/h7-12H2,1-6H3/q+2InChIKey
AXOIZCJOOAYSMI-UHFFFAOYSA-NSmiles
C[N+](C)Toxicity
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
dog | LDLo | intravenous | 300ug/kg (0.3mg/kg) | Archives Internationales de Pharmacodynamie et de Therapie. Vol. 88, Pg. 1, 1951. | |
human | TDLo | intravenous | 1430ug/kg (1.43mg/kg) | LUNGS, THORAX, OR RESPIRATION: STRUCTURAL OR FUNCTIONAL CHANGE IN TRACHEA OR BRONCHI | Anaesthesist. Vol. 21, Pg. 27, 1972. |
infant | TDLo | intravenous | 1600ug/kg (1.6mg/kg) | CARDIAC: OTHER CHANGES | British Journal of Anesthesia. Vol. 58, Pg. 576, 1986. |
mouse | LD50 | intraperitoneal | 2140ug/kg (2.14mg/kg) | Archives Internationales de Pharmacodynamie et de Therapie. Vol. 152, Pg. 277, 1964. | |
mouse | LD50 | intravenous | 280ug/kg (0.28mg/kg) | Research Communications in Chemical Pathology and Pharmacology. Vol. 1, Pg. 141, 1970. | |
mouse | LD50 | oral | 125mg/kg (125mg/kg) | "Drug Dosages in Laboratory Animals - A Handbook," Rev. ed., Barnes, C.D., and L.G. Eltherington, Berkeley, Univ. of California Press, 1973Vol. -, Pg. -, 1965. | |
mouse | LD50 | subcutaneous | 7500ug/kg (7.5mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: DYSPNEA | Arzneimittel-Forschung. Drug Research. Vol. 15, Pg. 126, 1965. |
rabbit | LD50 | intravenous | 1mg/kg (1mg/kg) | Archives Internationales de Pharmacodynamie et de Therapie. Vol. 88, Pg. 1, 1951. | |
rat | LD50 | subcutaneous | 3400ug/kg (3.4mg/kg) | Pharmacology and Toxicology. English translation of FATOAO. Vol. 21, Pg. 473, 1958. | |
women | TDLo | unreported | 1818ug/kg (1.818mg/kg) | CARDIAC: OTHER CHANGES | South African Medical Journal. Vol. 68, Pg. 601, 1985. |